Business Description
Synergy Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US8716393082
Compare
Compare
Traded in other countries / regions
IPO Date
2014-01-23Description
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.38 | |||||
| Equity-to-Asset | -1.16 | |||||
| Debt-to-Equity | -1.24 | |||||
| Debt-to-EBITDA | -0.88 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -20.81 | |||||
| Beneish M-Score | -0.7 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 0.5 | |||||
| 3-Year EPS without NRI Growth Rate | 0.7 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | 22.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 18.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.52 | |||||
| Quick Ratio | 0.38 | |||||
| Days Inventory | 407.73 | |||||
| Days Sales Outstanding | 81.41 | |||||
| Days Payable | 275.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.94 | |||||
| Operating Margin % | -327.83 | |||||
| Net Margin % | -332.11 | |||||
| FCF Margin % | -294.18 | |||||
| ROA % | -109.9 | |||||
| ROC (Joel Greenblatt) % | -11539.42 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.06 | |||||
| EV-to-EBIT | -0.56 | |||||
| EV-to-EBITDA | -0.56 | |||||
| EV-to-Revenue | 1.83 | |||||
| Earnings Yield (Greenblatt) % | -178.57 | |||||
| FCF Yield % | -5300.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Synergy Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 34.913 | ||
| EPS (TTM) (€) | -0.48 | ||
| Beta | 0 | ||
| Volatility % | 352.6 | ||
| 14-Day RSI | 18.84 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0.01 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0 - 1.77 | ||
| Shares Outstanding (Mil) | 248.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Synergy Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Synergy Pharmaceuticals Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Synergy Pharmaceuticals Inc Frequently Asked Questions
What is Synergy Pharmaceuticals Inc(STU:S90)'s stock price today?
The current price of STU:S90 is €0.00. The 52 week high of STU:S90 is €1.77 and 52 week low is €0.00.
When is next earnings date of Synergy Pharmaceuticals Inc(STU:S90)?
The next earnings date of Synergy Pharmaceuticals Inc(STU:S90) is .
Does Synergy Pharmaceuticals Inc(STU:S90) pay dividends? If so, how much?
Synergy Pharmaceuticals Inc(STU:S90) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers